Tauriga Sciences Company Profile (OTCMKTS:TAUG)

About Tauriga Sciences (OTCMKTS:TAUG)

Tauriga Sciences logoTauriga Sciences, Inc. is a diversified company. The Company is focused on the development of technology platform in the nano-robotics space. The Company is engaged in acquiring and building a portfolio of technology assets.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: OTCMKTS:TAUG
  • CUSIP: N/A
  • Web: www.tauriga.com
Capitalization:
  • Market Cap: $1.61 million
  • Outstanding Shares: 1,610,397,000
Average Prices:
  • 50 Day Moving Avg: $0.00
  • 200 Day Moving Avg: $0.00
  • 52 Week Range: $0.00 - $0.01
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -0.10
  • P/E Growth: 0.000
Sales & Book Value:
  • Annual Revenue: N/A
  • Price / Sales: N/A
  • Book Value: $0.00 per share
  • Price / Book: -0.50
Profitability:
  • EBIDTA: ($2,530,000.00)
  • Return on Assets: -28,126.90%
Debt:
  • Current Ratio: 0.01%
  • Quick Ratio: 0.01%
Misc:
  • Average Volume: 7.02 million shs.
  • Beta: 1.05
 

Frequently Asked Questions for Tauriga Sciences (OTCMKTS:TAUG)

What is Tauriga Sciences' stock symbol?

Tauriga Sciences trades on the OTCMKTS under the ticker symbol "TAUG."

Who are some of Tauriga Sciences' key competitors?

Who are Tauriga Sciences' key executives?

Tauriga Sciences' management team includes the folowing people:

  • Seth M. Shaw, Chairman of the Board, Chief Executive Officer

How do I buy Tauriga Sciences stock?

Shares of Tauriga Sciences can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Tauriga Sciences' stock price today?

One share of Tauriga Sciences stock can currently be purchased for approximately $0.00.


MarketBeat Community Rating for Tauriga Sciences (OTCMKTS TAUG)
Community Ranking:  NaN out of 5 ()
Outperform Votes:  0 (Vote Outperform)
Underperform Votes:  0 (Vote Underperform)
Total Votes:  0
MarketBeat's community ratings are surveys of what our community members think about Tauriga Sciences and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Tauriga Sciences (OTCMKTS:TAUG) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Tauriga Sciences (OTCMKTS:TAUG)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Tauriga Sciences (OTCMKTS:TAUG)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Tauriga Sciences (OTCMKTS:TAUG)
Current Year EPS Consensus Estimate: $-0.010 EPS
Next Year EPS Consensus Estimate: $-0.010 EPS

Dividends

Dividend History for Tauriga Sciences (OTCMKTS:TAUG)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Tauriga Sciences (OTCMKTS:TAUG)
Insider Ownership Percentage: 4.49%
Insider Trades by Quarter for Tauriga Sciences (OTCMKTS:TAUG)
Insider Trades by Quarter for Tauriga Sciences (OTCMKTS:TAUG)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/8/2016Thomas James GrahamDirectorSell72,500$0.01$725.00View SEC Filing  
3/23/2015Stella M SungCEOBuy800,000$0.01$8,000.00View SEC Filing  
10/7/2014Stella M SungCEOBuy1,440,000$0.01$14,400.00View SEC Filing  
8/11/2014Bacterial Robotics, LlcMajor ShareholderSell3,500,000$0.03$105,000.00View SEC Filing  
6/24/2014Stella M SungCEOBuy200,000$0.02$4,000.00View SEC Filing  
10/29/2013Seth M ShawCEOBuy315,000$0.03$9,450.00View SEC Filing  
9/3/2013Seth M ShawCEOBuy700,000$0.02$14,000.00View SEC Filing  
8/16/2013Seth M ShawCEOBuy425,000$0.02$8,500.00View SEC Filing  
8/9/2013Seth M ShawCEOBuy400,000$0.02$8,000.00View SEC Filing  
8/7/2013Seth M ShawCEOBuy250,000$0.02$5,000.00View SEC Filing  
8/6/2013Seth M ShawCEOBuy975,000$0.02$19,500.00View SEC Filing  
6/18/2013Stella M SungCOOBuy140,000$0.05$7,000.00View SEC Filing  
5/30/2013Seth M ShawCEOBuy100,000$0.06$6,000.00View SEC Filing  
5/24/2013Stella M SungCOOBuy50,000$0.06$3,000.00View SEC Filing  
5/15/2013Seth M ShawCEOBuy100,000$0.07$7,000.00View SEC Filing  
5/15/2013Stella M SungCOOBuy125,000$0.08$10,000.00View SEC Filing  
5/7/2013Seth M ShawCEOBuy200,000$0.08$16,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Tauriga Sciences (OTCMKTS:TAUG)
Latest Headlines for Tauriga Sciences (OTCMKTS:TAUG)
Source:
DateHeadline
finance.yahoo.com logoTauriga Sciences Inc. Assigned Trial Date on November 6, 2017 from United States District Court New Jersey
finance.yahoo.com - May 24 at 8:59 AM
finance.yahoo.com logoTauriga Sciences Inc. Prepares to Launch Cupuacu Butter Lip Balm Product Incorporating Improved Label Design and Graphics
finance.yahoo.com - May 17 at 8:03 PM
finance.yahoo.com logoTauriga Sciences Inc. Enters into Three Comprehensive Amendment Agreements with Existing Debt Holder Group 10 Holdings LLC
finance.yahoo.com - May 16 at 8:49 AM
finance.yahoo.com logoTauriga Sciences Inc. Confirms Court Date on May 23, 2017 Concerning the Motions to Set Matter For Trial and Trial By Jury
finance.yahoo.com - April 28 at 10:15 PM
finance.yahoo.com logoTauriga Sciences Inc. Secures More than $100,000 USD of Additional Funding from Existing Institutional & Accredited Individual Investors
finance.yahoo.com - March 28 at 8:01 PM
finance.yahoo.com logoTauriga Sciences, Inc. Notified by Federal District Court New Jersey of April 17, 2017 Trial Status Conference
finance.yahoo.com - March 7 at 8:52 AM
finance.yahoo.com logoTauriga Sciences, Inc. Receives Notification from DTCC That the Company has Been Approved for DWAC Services
finance.yahoo.com - January 28 at 6:52 AM
finance.yahoo.com logoTauriga Sciences, Inc. Featured in Prestigious London, U.K. Based Cosmetics Business Publication
finance.yahoo.com - January 5 at 6:58 AM
finance.yahoo.com logoTauriga Sciences, Inc. RolLeaf Branded Product Now Complete; Cannabidiol "CBD" Infused Roll On Product for Muscle Tension Relief
finance.yahoo.com - January 4 at 5:48 AM
finance.yahoo.com logoTauriga Sciences, Inc. Enters into Non-Exclusive License Agreement to Market Cupuacu Butter Lip Balm
finance.yahoo.com - December 29 at 8:04 PM
finance.yahoo.com logoCORRECTION - Tauriga Sciences, Inc. Sells Majority Stake of Pilus Energy Subsidiary to Open Therapeutics LLC
finance.yahoo.com - December 28 at 7:57 PM
finance.yahoo.com logoTauriga Sciences, Inc. Sells Majority Stake of Pilus Energy Subsidiary to Open Therapeutics LLC
finance.yahoo.com - December 27 at 8:51 AM
finance.yahoo.com logoTauriga Sciences, Inc. Provides Update on Status of its Lawsuit Against Cowan Gunteski & Co. PA
finance.yahoo.com - December 23 at 1:15 AM
finance.yahoo.com logoTauriga Sciences, Inc. Updates Shareholders on Efforts to Uplist to OTCQB Tier
finance.yahoo.com - December 15 at 6:40 AM
finance.yahoo.com logoTauriga Sciences, Inc. Reports Progress in Completing the Formulation of its First ColluMauxil Branded Product, a Cannabidiol "CBD" Infused Roll On for Muscle Tension Relief
finance.yahoo.com - December 7 at 8:15 AM
finance.yahoo.com logoTauriga Sciences, Inc. Becomes Current in its SEC Periodic Filings and Regains Fully Reporting Status
finance.yahoo.com - December 6 at 8:15 AM
finance.yahoo.com logoTauriga Sciences Inc. to Form Wholly Owned Subsidiary Focused on the Development, Marketing and Distribution of Products that Target Muscle Tension
finance.yahoo.com - November 15 at 11:35 AM
finance.yahoo.com logoTauriga Sciences Inc. Files its Form 10-Q for 1st Fiscal Quarter of 2016
finance.yahoo.com - November 9 at 10:40 AM
finance.yahoo.com logoTauriga Sciences Inc. Files its Form 10-K for Fiscal Year End 2016
finance.yahoo.com - October 14 at 10:54 AM
finance.yahoo.com logoTauriga Sciences, Inc. Files Two Motions in Federal Court to Both Compel the Deposition of Mr. William Meyler and the Written Discovery Materials to Be Provided by Cowan Gunteski & Co. P.A.
finance.yahoo.com - August 31 at 11:12 AM
finance.yahoo.com logoTauriga Sciences, Inc. Files Its Third Fiscal Quarter 2016 Form 10Q and Continues to Report Meaningful Progress on Multiple Fronts
finance.yahoo.com - August 10 at 10:51 AM
finance.yahoo.com logoTauriga Sciences Inc. Secures Requisite Additional Capital to Finance Auditor Engagement Through Completion of First Fiscal Quarter 2017 Audit; Period Ending June 30, 2016
finance.yahoo.com - August 4 at 10:55 AM
biz.yahoo.com logoTAURIGA SCIENCES, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
biz.yahoo.com - July 18 at 3:07 PM
finance.yahoo.com logoTauriga Sciences Inc. Responds in Federal Court to the Multiple Motions Filed by Cowan Gunteski
finance.yahoo.com - July 7 at 7:00 AM
finance.yahoo.com logoTauriga Sciences, Inc. Granted Extension Until July 6, 2016 to Respond to Motions Recently Filed by Cowan Gunteski & Co. P.A.
finance.yahoo.com - June 30 at 4:31 PM
biz.yahoo.com logoTAURIGA SCIENCES, INC. Files SEC form 10-Q, Quarterly Report
biz.yahoo.com - June 29 at 4:11 PM
finance.yahoo.com logoTauriga Sciences, Inc. Extinguishes the Outstanding Judgement Owed to Cherry Bekaert LLP for Total Cash Payment of $53,707.91 USD
finance.yahoo.com - June 28 at 7:00 AM
finance.yahoo.com logoTauriga Sciences Inc. Completes Additional $194,000 USD Private Placement With Six Connecticut and Rhode Island Based Accredited Individual Investors
finance.yahoo.com - June 27 at 12:42 PM
finance.yahoo.com logoTauriga Sciences Inc. Issues Comprehensive Update to Shareholders and Reports Significant Progress on Multiple Fronts
finance.yahoo.com - June 1 at 10:30 AM

Social

Chart

Tauriga Sciences (TAUG) Chart for Monday, May, 29, 2017

This page was last updated on 5/29/2017 by MarketBeat.com Staff